I find today's PR interesting for the reason noted below from the FDA website. I don't know for sure, but patent approval sure would seem to help the FDA review along, regardless of where you are in the overall process.....with the end of PII meeting coming up for B-OM by the end of the year, this sure seems like a nice story for IPIX to be able to tell at that meeting. Furthemore, if I was a BP interested in B-OM, this would certainly add to my confidence level moving forward. All IMHO.

"Patent information is required to be submitted with all new drug applications (NDAs) and certain supplemental applications (sNDAs) on Form FDA 3542a at the time of submission of the NDA or sNDA"